The digital twins market in biotechnology is experiencing significant growth, projected to expand at a rate of 42.2% to reach USD 45 billion by 2033, up from USD 3.26 billion currently. Digital twins are virtual models that simulate biological systems and processes, allowing for enhanced decision-making and efficiency in drug development, clinical trials, and manufacturing. Key trends include the integration of AI and IoT, with opportunities arising from advancements in predictive analytics and simulation technologies. Challenges such as data privacy and implementation costs remain, but North America leads the market, while Asia Pacific shows the fastest growth potential. Major companies in this space include Siemens, IBM, and Microsoft, among others.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.openpr.com/news/4486190/digital-twins-in-biotech-market-is-booming-worldwide-dassault
